Michael Richman - Mar 29, 2024 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
President & CEO, Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman
Stock symbol
NXTC
Transactions as of
Mar 29, 2024
Transactions value $
$0
Form type
4
Date filed
4/2/2024, 04:44 PM
Previous filing
Feb 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Employee Stock Option (Right to Buy) Award $0 +244K $0.00 244K Mar 29, 2024 Common Stock 244K $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one year anniversary of the grant, March 29, 2025.